ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (ACAD)

14.555
-0.105
( -0.72% )
Updated: 02:00:02

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 118.46M165.24M211.7M231.04M205.83M241.96M250.4M259.6M
Operating Income -53.58M3.04M-57.78M34.94M15.21M30.44M31.64M6.99M
Pre Tax Income -44.94M6.34M-52.14M39.7M21M37.18M38.81M161.09M
Net Income -43.02M1.11M-65.18M45.8M16.56M33.39M32.77M143.74M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -53.58M3.04M-52.67M34.94M15.5M30.82M32.22M154.08M
EBITDA -53.16M4.8M-56.05M36.58M20.74M33.01M34.21M12.2M
Year End 31 December 2024 20172018201920202021202220232024
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 124.9M223.81M339.08M441.76M484.15M517.24M726.44M957.8M
Operating Income -292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M84.28M
Pre Tax Income -288.28M-243.94M-234.38M-280.97M-167.52M-213.44M-51.04M258.08M
Net Income -289.4M-245.19M-235.26M-281.58M-167.87M-215.98M-61.29M226.45M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.326-1.704-1.515-1.764-1.043-1.333-0.3731.361
EBIT -292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M232.62M
EBITDA -289.7M-244.44M-243.78M-283.65M-167.1M-221.57M-67.83M100.16M